Pancreatic Cancer Patient Recruitment in New York

TheraNovex connects clinical trial sponsors with pre-screened, eligible Pancreatic Cancer patients across New York, including New York City, Buffalo, Rochester, and beyond.

Pancreatic cancer patient recruitment for resectable, locally advanced, and metastatic clinical trials.

Who qualifies: Adults with pancreatic ductal adenocarcinoma (PDAC) across all stages, including KRAS and BRCA mutation carriers.

Recruitment challenges: Rapid disease progression and performance status decline require fast enrollment.

Our approach: GI oncology and surgical oncology referral networks with expedited pre-screening protocols.

Our recruitment network spans all major metropolitan areas in New York, ensuring broad geographic coverage for your Pancreatic Cancer trial.